Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography

BACKGROUND: Signal-averaged electrocardiography detects low-amplitude signals designated as late potentials which are strongly related to myocardial damage. We aimed to search for the possible relation between the myocardial effects of doxorubicin and signal-averaged electrocardiographic parameters....

Full description

Bibliographic Details
Main Authors: HAKAN SAKALLI, DIDEM ARSLAN TAS, OSMAN KARAARSLAN, HUSEYIN MERTSOYLU, BAHATTIN YILMAZ, ABDULLAH CANATAROGLU
Format: Article
Language:English
Published: Cukurova University 2013-04-01
Series:Çukurova Üniversitesi Tıp Fakültesi Dergisi
Subjects:
Online Access:http://www.scopemed.org/fulltextpdf.php?mno=26301
_version_ 1797923894566322176
author HAKAN SAKALLI
DIDEM ARSLAN TAS
OSMAN KARAARSLAN
HUSEYIN MERTSOYLU
BAHATTIN YILMAZ
ABDULLAH CANATAROGLU
author_facet HAKAN SAKALLI
DIDEM ARSLAN TAS
OSMAN KARAARSLAN
HUSEYIN MERTSOYLU
BAHATTIN YILMAZ
ABDULLAH CANATAROGLU
author_sort HAKAN SAKALLI
collection DOAJ
description BACKGROUND: Signal-averaged electrocardiography detects low-amplitude signals designated as late potentials which are strongly related to myocardial damage. We aimed to search for the possible relation between the myocardial effects of doxorubicin and signal-averaged electrocardiographic parameters. METHODS: Fortyeight patients who received doxorubicin included chemotherapy were enrolled. Signal-averaged electrocardiographic parameters were detected by using 3 parameters; filtered QRS (fQRS), the square root of the voltage obtained during the last 40 milliseconds of the duration of fQRS (RMS40), the duration starting from the last 40 miliseconds of fQRS till the decrease of voltage under 40 microvolts. (HFLA40). Ejection fractions of the patients were measured by echocardiographic evaluation. RESULTS: Median age was 44 (27-70) years. Mean cumulative doxorubicin dosage was 475.56±98.45 mg. Mean values of the measured signal-averaged electrocardiographic parameters were as follows; fQRS: 78.27±10.74 miliseconds, RMS40:115.10±50.23 and HFLA was 21.95±8.39 microvolts . The doses of doxorubicin showed a positive correlation with fQRS (r=0.28, p=0.02) and a negative correlation with RMS40 (r=-.31,p=0.03). There was no correlation between the doxorubicin dosage and the ejection fraction of the patients (r=.18, p=0.22). CONCLUSION: Our results suggested that significant correlations are present between fQRS and RMS40 and cumulative doxorubicin dosages. Therefore, signal-averaged electrocardiographic parameters may be of value for predicting the prognosis of the patients who have received doxorubicin included chemotherapy. [Cukurova Med J 2013; 38(2.000): 241-249]
first_indexed 2024-04-10T14:53:21Z
format Article
id doaj.art-5930e35401274125925cbd4cce74afa7
institution Directory Open Access Journal
issn 0250-5150
language English
last_indexed 2024-04-10T14:53:21Z
publishDate 2013-04-01
publisher Cukurova University
record_format Article
series Çukurova Üniversitesi Tıp Fakültesi Dergisi
spelling doaj.art-5930e35401274125925cbd4cce74afa72023-02-15T16:07:30ZengCukurova UniversityÇukurova Üniversitesi Tıp Fakültesi Dergisi0250-51502013-04-01382241249Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged ElectrocardiographyHAKAN SAKALLIDIDEM ARSLAN TASOSMAN KARAARSLANHUSEYIN MERTSOYLUBAHATTIN YILMAZABDULLAH CANATAROGLUBACKGROUND: Signal-averaged electrocardiography detects low-amplitude signals designated as late potentials which are strongly related to myocardial damage. We aimed to search for the possible relation between the myocardial effects of doxorubicin and signal-averaged electrocardiographic parameters. METHODS: Fortyeight patients who received doxorubicin included chemotherapy were enrolled. Signal-averaged electrocardiographic parameters were detected by using 3 parameters; filtered QRS (fQRS), the square root of the voltage obtained during the last 40 milliseconds of the duration of fQRS (RMS40), the duration starting from the last 40 miliseconds of fQRS till the decrease of voltage under 40 microvolts. (HFLA40). Ejection fractions of the patients were measured by echocardiographic evaluation. RESULTS: Median age was 44 (27-70) years. Mean cumulative doxorubicin dosage was 475.56±98.45 mg. Mean values of the measured signal-averaged electrocardiographic parameters were as follows; fQRS: 78.27±10.74 miliseconds, RMS40:115.10±50.23 and HFLA was 21.95±8.39 microvolts . The doses of doxorubicin showed a positive correlation with fQRS (r=0.28, p=0.02) and a negative correlation with RMS40 (r=-.31,p=0.03). There was no correlation between the doxorubicin dosage and the ejection fraction of the patients (r=.18, p=0.22). CONCLUSION: Our results suggested that significant correlations are present between fQRS and RMS40 and cumulative doxorubicin dosages. Therefore, signal-averaged electrocardiographic parameters may be of value for predicting the prognosis of the patients who have received doxorubicin included chemotherapy. [Cukurova Med J 2013; 38(2.000): 241-249]http://www.scopemed.org/fulltextpdf.php?mno=26301Signal-averaged electrocardiographydoxorubicincardiotoxicity
spellingShingle HAKAN SAKALLI
DIDEM ARSLAN TAS
OSMAN KARAARSLAN
HUSEYIN MERTSOYLU
BAHATTIN YILMAZ
ABDULLAH CANATAROGLU
Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
Çukurova Üniversitesi Tıp Fakültesi Dergisi
Signal-averaged electrocardiography
doxorubicin
cardiotoxicity
title Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
title_full Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
title_fullStr Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
title_full_unstemmed Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
title_short Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
title_sort evaluation of doxorubicin cardiomyopathy by signal averaged electrocardiography
topic Signal-averaged electrocardiography
doxorubicin
cardiotoxicity
url http://www.scopemed.org/fulltextpdf.php?mno=26301
work_keys_str_mv AT hakansakalli evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography
AT didemarslantas evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography
AT osmankaraarslan evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography
AT huseyinmertsoylu evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography
AT bahattinyilmaz evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography
AT abdullahcanataroglu evaluationofdoxorubicincardiomyopathybysignalaveragedelectrocardiography